Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBridge Biosciences (NBP) Other Non-Current Liabilities (2020 - 2022)

NovaBridge Biosciences (NBP) has disclosed Other Non-Current Liabilities for 3 consecutive years, with $2.4 million as the latest value for Q4 2022.

  • Quarterly Other Non-Current Liabilities rose 2.11% to $2.4 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $2.4 million through Dec 2022, up 2.11% year-over-year, with the annual reading at $2.5 million for FY2022, 4.95% up from the prior year.
  • Other Non-Current Liabilities for Q4 2022 was $2.4 million at NovaBridge Biosciences, up from $2.3 million in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $2.4 million in Q4 2022, with the low at $1.4 million in Q4 2020.
  • Average Other Non-Current Liabilities over 3 years is $2.0 million, with a median of $2.3 million recorded in 2021.
  • The sharpest move saw Other Non-Current Liabilities soared 72.48% in 2021, then grew 2.11% in 2022.
  • Over 3 years, Other Non-Current Liabilities stood at $1.4 million in 2020, then surged by 72.48% to $2.3 million in 2021, then grew by 2.11% to $2.4 million in 2022.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $2.4 million, $2.3 million, and $1.4 million for Q4 2022, Q4 2021, and Q4 2020 respectively.